is retatrutide a glp 1 drug Unapproved weight loss causes extreme side effects Retatrutide—A Game Changer in Obesity

Genetic Pathways and Peptide Response: A Precision Lens Recent research highlights genetic variants in GLP-1 receptor (GLP1R), glucose-dependent insulinotropic peptide receptor (GIPR), fat mass and obesity associated gene (FTO), and melanocortin-4 receptor (MC4R) that may correlate with baseline BMI, weight-loss trajectory, and side-effect tolerability

A pesar de ello aun faltan estudios especficos sobre la seguridad y la eficacia del AR GLP-1 en pacientes con IC

PMID 37351564 Check |pmid= value (help)

Data availability All raw LCMS/MS plasma metabolomics data generated during this study are publicly available in Figshare at References Bralten J, van Hulzen KJ, Martens MB, Galesloot TE, Arias Vasquez A, Kiemeney LA, Buitelaar JK, Muntjewerff JW, Franke B, Poelmans G

Review on the effects obesity treatment with acupuncture and phytoacupuncture